While complete Mecp2 knockouts in vivo are unattainable due to lethality, the use of conditional Mecp2 knockouts could be an efficacious option to explore the sufficiency of LINE-1 in models of Rett syndrome and ASD. The gene discussed is MECP2; the disease is atypical Rett syndrome.